Terms: = Breast cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Clinical Outcome
3 results:
1. Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL.
Thill M; Zahn MO; Welt A; Stickeler E; Nusch A; Fietz T; Rauh J; Wetzel N; Kruggel L; Jänicke M; Marschner N; Harbeck N; Wöckel A; Decker T;
Breast Cancer Res Treat; 2023 Apr; 198(3):545-553. PubMed ID: 36807725
[TBL] [Abstract] [Full Text] [Related]
2. [Prognostic values of grading system for lymph vessel tumor emboli in patients with invasive breast carcinomas of no special type].
Yue M; Li F; Deng HY; Zhang LL; Liu YP
Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):754-758. PubMed ID: 29061019
[No Abstract] [Full Text] [Related]
3. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival.
Powe DG; Voss MJ; Zänker KS; Habashy HO; Green AR; Ellis IO; Entschladen F
Oncotarget; 2010 Nov; 1(7):628-38. PubMed ID: 21317458
[TBL] [Abstract] [Full Text] [Related]
